SEOUL, South Korea and BOSTON, May 13, 2025 /PRNewswire/ -- iNtRON Biotechnology, Inc., a biotechnology company focused on developing innovative endolysin-based new biological drug for superbugs and ...
Researchers at University of Tsukuba have decoded the nuclear genome of Amorphochlora amoebiformis, a unicellular marine alga belonging to the chlorarachniophyte group. The work is published in the ...
iNtRON stated that following the proprietary development of the Robot Bacteriophage 2 nd generation technology, additional in-vitro evolution technology was applied. The Company previously secured the ...
The MarketWatch News Department was not involved in the creation of this content. -- Gram-negative bacterial infections are becoming an increasingly serious global health issue -- U.S. patent ...
Development of Bacteriophages targeting strains causing urinary tract infections Establishment of collaboration with the US Army and investigation of groundwork for entering the US defense market ...
According to the company's explanation, bacteriophages have been mainly used for R&D on bacterial infectious diseases, but recently the scope of application of bacteriophages has been expanded to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results